Real-time enrollment status for this prostatic neoplasms, castration-resistant clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 2:53 AM UTC
| NCT Number | NCT07677267 |
| Recruiting Status | Recruiting |
| Condition | Prostatic Neoplasms, Castration-Resistant |
| Phase | Clinical Trial |
| Target Enrollment | 1,067 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | July 16, 2026 (4 days ago) |
As of July 20, 2026: Clinical trial NCT07677267 is currently recruiting participants. This clinical trial study for prostatic neoplasms, castration-resistant is actively seeking new participants at 1 location across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07677267 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07677267 was last updated 4 days ago (July 16, 2026). HelloStudys verifies this status automatically.